These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18776126)

  • 1. Toll-like receptor 9 affects severity of IgA nephropathy.
    Suzuki H; Suzuki Y; Narita I; Aizawa M; Kihara M; Yamanaka T; Kanou T; Tsukaguchi H; Novak J; Horikoshi S; Tomino Y
    J Am Soc Nephrol; 2008 Dec; 19(12):2384-95. PubMed ID: 18776126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary zinc is a key environmental modifier in the progression of IgA nephropathy.
    Maiguma M; Suzuki Y; Suzuki H; Okazaki K; Aizawa M; Muto M; Tomino Y
    PLoS One; 2014; 9(2):e90558. PubMed ID: 24587392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin A nephropathy.
    Chen X; Peng S; Zeng H; Fu A; Zhu Q
    Indian J Pharmacol; 2015; 47(1):27-33. PubMed ID: 25821307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy.
    Kano T; Suzuki H; Makita Y; Fukao Y; Suzuki Y
    Kidney Int; 2021 Aug; 100(2):364-376. PubMed ID: 33961870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine Models of Human IgA Nephropathy.
    Suzuki H; Suzuki Y
    Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tonsillar TLR9 expression and efficacy of tonsillectomy with steroid pulse therapy in IgA nephropathy patients.
    Sato D; Suzuki Y; Kano T; Suzuki H; Matsuoka J; Yokoi H; Horikoshi S; Ikeda K; Tomino Y
    Nephrol Dial Transplant; 2012 Mar; 27(3):1090-7. PubMed ID: 21778277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the pathogenesis of IgA nephropathy: do toll like receptor 9-B cell activation factor-IgA class switching recombination signaling axis induce IgA hyper-production?
    Liu Y; Liu H; Peng Y; Liu F
    Ren Fail; 2014 Jul; 36(6):970-3. PubMed ID: 24828398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different pathological roles of toll-like receptor 9 on mucosal B cells and dendritic cells in murine IgA nephropathy.
    Kajiyama T; Suzuki Y; Kihara M; Suzuki H; Horikoshi S; Tomino Y
    Clin Dev Immunol; 2011; 2011():819646. PubMed ID: 21765852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR9 and BAFF: their expression in patients with IgA nephropathy.
    Li W; Peng X; Liu Y; Liu H; Liu F; He L; Liu Y; Zhang F; Guo C; Chen G; Zhang L; Dong Z; Peng Y
    Mol Med Rep; 2014 Sep; 10(3):1469-74. PubMed ID: 24993857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide scan identifies a copy number variable region at 3p21.1 that influences the TLR9 expression levels in IgA nephropathy patients.
    Sallustio F; Cox SN; Serino G; Curci C; Pesce F; De Palma G; Papagianni A; Kirmizis D; Falchi M; Schena FP;
    Eur J Hum Genet; 2015 Jul; 23(7):940-8. PubMed ID: 25293716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for genetic factors in the development and progression of IgA nephropathy.
    Hsu SI; Ramirez SB; Winn MP; Bonventre JV; Owen WF
    Kidney Int; 2000 May; 57(5):1818-35. PubMed ID: 10792601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.
    Takahara M; Nagato T; Nozaki Y; Kumai T; Katada A; Hayashi T; Harabuchi Y
    Cell Immunol; 2019 Jul; 341():103925. PubMed ID: 31088610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different Expression Patterns of Toll-Like Receptor mRNAs in Blood Mononuclear Cells of IgA Nephropathy and IgA Vasculitis with Nephritis.
    Saito A; Komatsuda A; Kaga H; Sato R; Togashi M; Okuyama S; Wakui H; Takahashi N
    Tohoku J Exp Med; 2016 Nov; 240(3):199-208. PubMed ID: 27818460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
    He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
    J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy.
    Lee M; Suzuki H; Ogiwara K; Aoki R; Kato R; Nakayama M; Fukao Y; Nihei Y; Kano T; Makita Y; Muto M; Yamada K; Suzuki Y
    Kidney Int; 2023 Nov; 104(5):943-955. PubMed ID: 37648155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23.
    Suzuki H; Suzuki Y; Yamanaka T; Hirose S; Nishimura H; Toei J; Horikoshi S; Tomino Y
    J Am Soc Nephrol; 2005 May; 16(5):1289-99. PubMed ID: 15772254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN).
    Yamamoto R; Nagasawa Y; Shoji T; Inoue K; Uehata T; Kaneko T; Okada T; Yamauchi A; Tsubakihara Y; Imai E; Isaka Y; Rakugi H
    Nephrol Dial Transplant; 2009 Dec; 24(12):3686-94. PubMed ID: 19420105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-1 levels are increased in patients with IgA nephropathy.
    Tokunaga K; Uto H; Takami Y; Mera K; Nishida C; Yoshimine Y; Fukumoto M; Oku M; Sogabe A; Nosaki T; Moriuchi A; Oketani M; Ido A; Tsubouchi H
    Biochem Biophys Res Commun; 2010 Aug; 399(2):144-9. PubMed ID: 20637724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.
    Vuong MT; Hahn-Zoric M; Lundberg S; Gunnarsson I; van Kooten C; Wramner L; Seddighzadeh M; Fernström A; Hanson LÅ; Do LT; Jacobson SH; Padyukov L
    Kidney Int; 2010 Dec; 78(12):1281-7. PubMed ID: 20811333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like Receptor 4 Signaling Pathway in the Protective Effect of Pioglitazone on Experimental Immunoglobulin A Nephropathy.
    Zou JN; Xiao J; Hu SS; Fu CS; Zhang XL; Zhang ZX; Lu YJ; Chen WJ; Ye ZB
    Chin Med J (Engl); 2017 Apr; 130(8):906-913. PubMed ID: 28397719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.